Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics
- 1 September 1984
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 26 (3) , 308-318
- https://doi.org/10.1038/ki.1984.174
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunctionAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysisAntimicrobial Agents and Chemotherapy, 1983
- Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjectsAntimicrobial Agents and Chemotherapy, 1982
- Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic diseaseAntimicrobial Agents and Chemotherapy, 1981
- Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysisAntimicrobial Agents and Chemotherapy, 1981
- Moxalactam pharmacokinetics during hemodialysisAntimicrobial Agents and Chemotherapy, 1981
- Peritoneal dialysis during peritonitisKidney International, 1981
- Cefoxitin disposition during peritoneal dialysisAntimicrobial Agents and Chemotherapy, 1981
- Clearance calculations in hemodialysis: Application to blood, plasma, and dialysate measurements for ethambutolJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Pharmacokinetics of Cephalosporins in Patients with Normal or Reduced Renal FunctionThe Journal of Infectious Diseases, 1978